Price $6.75 |
Market Cap
64.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.1
|
P/B
-
|
P/S
2.32
|
Dividend %
-
|
|
P/CF
33.3
|
P/FCF
13.9
|
Op. Cash Flow
5.1K
|
FCF
0.6
|
|
Op. Margin
18.40%
|
Net Margin
-2.50%
|
ROE
4.90%
|
ROI
-128.80%
|
|
ROA
-3.00%
|
EPS Growth
-4.90%
|
Current Ratio
0.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.33 | - | - | 39.3M | Strong Buy |
| Vaxart Inc (VXRT) | $3.20 | - | - | 20.3M | Strong Buy |
| Altimmune Inc (ALT) | $4.65 | - | - | 17.4M | Strong Buy |
| Civitas Solutions Inc (CIVI) | $15.78 | - | - | 527.1M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $2.09 | - | - | 8.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
